MedTrace Logo

Effect of Blueberry Supplementation on Alzheimer's Biomarkers

NCT05172128 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2024-09-19

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to study the effects of blueberries on neuronal, glial, and pathology blood biomarkers in Mild Cognitive Impairment (MCI) and to estimate sample size for future confirmatory studies. The blood biomarkers to be measured are Neurofilament light (NfL), glial fibrillary acidic protein (GFAP), Aß40, Aß42, p-tau181, and cytokines, using an ultra-sensitive state-of-the-art immunoassay.

Conditions

Interventions

DIETARY_SUPPLEMENT

lyophilized blueberry supplement

lyophilized blueberry supplement bid

Sponsors & Collaborators

  • U.S. Highbush Blueberry Council

    collaborator OTHER

  • Duke University

    lead OTHER

Principal Investigators

  • Murali Doraiswamy, MD · Duke University

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-21
Primary Completion
2023-02-06
Completion
2023-02-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05172128 on ClinicalTrials.gov